oligodendroglioma |
Disease ID | 663 |
---|---|
Disease | oligodendroglioma |
Definition | A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655) |
Synonym | oligodendrogliomas |
Orphanet | |
DOID | |
UMLS | C0028945 |
MeSH | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:14) C0017636 | glioblastoma | 13 C0017636 | glioblastomas | 4 C0206716 | ganglioglioma | 3 C0334583 | pilocytic astrocytoma | 2 C0004114 | astrocytoma | 2 C0004114 | astrocytomas | 2 C0555198 | malignant glioma | 1 C0280793 | oligoastrocytoma | 1 C0555198 | malignant gliomas | 1 C0011649 | mature cystic teratoma | 1 C1368903 | cystic teratoma | 1 C0206719 | central neurocytoma | 1 C0007102 | colon cancer | 1 C0030312 | pancytopenia | 1 |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:10) |
Inferring Gene | Entrez_id | Symbol | Resource(Total Genes:8) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:134) 20 | ABCA2 | 1.435 | DISEASES 199 | AIF1 | 1.994 | DISEASES 55966 | AJAP1 | 2.638 | DISEASES 54840 | APTX | 1.743 | DISEASES 9048 | ARTN | 3.517 | DISEASES 430 | ASCL2 | 1.268 | DISEASES 121549 | ASCL4 | 2.614 | DISEASES 647219 | ASCL5 | 3.135 | DISEASES 10396 | ATP8A1 | 2.181 | DISEASES 546 | ATRX | 4.165 | DISEASES 63827 | BCAN | 1.246 | DISEASES 55859 | BEX1 | 1.674 | DISEASES 84707 | BEX2 | 1.674 | DISEASES 768 | CA9 | 1.139 | DISEASES 55799 | CACNA2D3 | 1.894 | DISEASES 815 | CAMK2A | 1.385 | DISEASES 816 | CAMK2B | 2.131 | DISEASES 137196 | CCDC26 | 3.185 | DISEASES 917 | CD3G | 1.107 | DISEASES 1029 | CDKN2A | 3.11 | DISEASES 3075 | CFH | 4.113 | DISEASES 163732 | CITED4 | 2.332 | DISEASES 25932 | CLIC4 | 1.269 | DISEASES 23019 | CNOT1 | 1.902 | DISEASES 1267 | CNP | 2.721 | DISEASES 1351 | COX8A | 2.569 | DISEASES 1454 | CSNK1E | 1.338 | DISEASES 1677 | DFFB | 1.404 | DISEASES 1729 | DIAPH1 | 1.2 | DISEASES 1730 | DIAPH2 | 1.429 | DISEASES 9077 | DIRAS3 | 1.109 | DISEASES 1809 | DPYSL3 | 1.15 | DISEASES 30845 | EHD3 | 1.741 | DISEASES 2068 | ERCC2 | 1.562 | DISEASES 389549 | FEZF1 | 1.078 | DISEASES 752 | FMNL1 | 1.634 | DISEASES 22862 | FNDC3A | 1.152 | DISEASES 8880 | FUBP1 | 5.162 | DISEASES 85476 | GFM1 | 1.019 | DISEASES 2673 | GFPT1 | 1.201 | DISEASES 29998 | GLTSCR1 | 2.613 | DISEASES 2778 | GNAS | 1.496 | DISEASES 392862 | GRID2IP | 2.356 | DISEASES 3020 | H3F3A | 3.345 | DISEASES 3039 | HBA1 | 1.154 | DISEASES 8350 | HIST1H3A | 1.552 | DISEASES 8352 | HIST1H3C | 1.339 | DISEASES 8351 | HIST1H3D | 1.552 | DISEASES 8353 | HIST1H3E | 1.344 | DISEASES 8968 | HIST1H3F | 1.552 | DISEASES 8355 | HIST1H3G | 1.552 | DISEASES 8357 | HIST1H3H | 1.552 | DISEASES 8354 | HIST1H3I | 1.552 | DISEASES 8356 | HIST1H3J | 1.342 | DISEASES 3231 | HOXD1 | 2.011 | DISEASES 3400 | ID4 | 2.556 | DISEASES 3418 | IDH2 | 4.868 | DISEASES 11009 | IL24 | 1.09 | DISEASES 9118 | INA | 2.724 | DISEASES 79191 | IRX3 | 1.254 | DISEASES 57670 | KIAA1549 | 3.974 | DISEASES 377007 | KLHL30 | 3.599 | DISEASES 8022 | LHX3 | 1.024 | DISEASES 4004 | LMO1 | 1.2 | DISEASES 9860 | LRIG2 | 3.199 | DISEASES 121227 | LRIG3 | 1.841 | DISEASES 55534 | MAML3 | 1.989 | DISEASES 4133 | MAP2 | 2.509 | DISEASES 4134 | MAP4 | 1.289 | DISEASES 4155 | MBP | 2.479 | DISEASES 4193 | MDM2 | 2.185 | DISEASES 4194 | MDM4 | 1.399 | DISEASES 27030 | MLH3 | 1.029 | DISEASES 4336 | MOBP | 1.685 | DISEASES 4337 | MOCS1 | 1.951 | DISEASES 10608 | MXD4 | 3.306 | DISEASES 23040 | MYT1L | 1.809 | DISEASES 10763 | NES | 2.128 | DISEASES 4763 | NF1 | 1.53 | DISEASES 4821 | NKX2-2 | 2.711 | DISEASES 388677 | NOTCH2NL | 1.735 | DISEASES 4857 | NOVA1 | 1.589 | DISEASES 4862 | NPAS2 | 1.097 | DISEASES 4916 | NTRK3 | 1.082 | DISEASES 116448 | OLIG1 | 3.202 | DISEASES 10215 | OLIG2 | 5.134 | DISEASES 4983 | OPHN1 | 1.367 | DISEASES 64098 | PARVG | 2.581 | DISEASES 57326 | PBXIP1 | 2.294 | DISEASES 9141 | PDCD5 | 1.123 | DISEASES 5154 | PDGFA | 1.692 | DISEASES 5155 | PDGFB | 2.575 | DISEASES 5178 | PEG3 | 1.059 | DISEASES 23187 | PHLDB1 | 1.777 | DISEASES 8605 | PLA2G4C | 2.365 | DISEASES 5329 | PLAUR | 1.116 | DISEASES 58473 | PLEKHB1 | 1.657 | DISEASES 11284 | PNKP | 1.532 | DISEASES 5422 | POLA1 | 2.295 | DISEASES 5424 | POLD1 | 1.139 | DISEASES 5451 | POU2F1 | 1.336 | DISEASES 57580 | PREX1 | 1.49 | DISEASES 8842 | PROM1 | 1.295 | DISEASES 5728 | PTEN | 3.212 | DISEASES 5787 | PTPRB | 1.32 | DISEASES 5803 | PTPRZ1 | 1.978 | DISEASES 9444 | QKI | 1.413 | DISEASES 146713 | RBFOX3 | 3.068 | DISEASES 23186 | RCOR1 | 1.409 | DISEASES 9699 | RIMS2 | 2.058 | DISEASES 8153 | RND2 | 2.215 | DISEASES 6135 | RPL11 | 1.146 | DISEASES 6141 | RPL18 | 1.133 | DISEASES 57142 | RTN4 | 1.69 | DISEASES 6280 | S100A9 | 1.042 | DISEASES 6565 | SLC15A2 | 1.647 | DISEASES 9353 | SLIT2 | 1.651 | DISEASES 6586 | SLIT3 | 1.564 | DISEASES 84631 | SLITRK2 | 2.661 | DISEASES 139065 | SLITRK4 | 2.669 | DISEASES 26050 | SLITRK5 | 2.177 | DISEASES 84189 | SLITRK6 | 2.212 | DISEASES 6663 | SOX10 | 1.597 | DISEASES 55553 | SOX6 | 1.109 | DISEASES 79582 | SPAG16 | 1.83 | DISEASES 10252 | SPRY1 | 1.686 | DISEASES 55959 | SULF2 | 1.043 | DISEASES 6938 | TCF12 | 2.034 | DISEASES 284486 | THEM5 | 1.1 | DISEASES 8848 | TSC22D1 | 2.454 | DISEASES 7317 | UBA1 | 1.108 | DISEASES 7316 | UBC | 1.398 | DISEASES 7422 | VEGFA | 1.268 | DISEASES 84619 | ZGPAT | 2.503 | DISEASES |
Locus | Symbol | Locus(Total Locus:2) |
Disease ID | 663 |
---|---|
Disease | oligodendroglioma |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:8) HP:0100843 | Glioblastoma | 14 HP:0002664 | Neoplasia | 9 HP:0009592 | Astrocytoma | 2 HP:0030692 | Brain tumor | 2 HP:0009733 | Glioma | 2 HP:0001250 | Seizures | 1 HP:0001876 | Low blood cell count | 1 HP:0003003 | Colon cancer | 1 |
Disease ID | 663 |
---|---|
Disease | oligodendroglioma |
Manually Symptom | UMLS | Name(Total Manually Symptoms:3) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:13) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs1042522 | 18393224 | 7157 | TP53 | umls:C0028945 | BeFree | Aiming to study the role of TP53 Pro47Ser and Arg72Pro on glioma susceptibility and oncologic prognosis of patients, we investigated the genotype distribution of these SNPs in 94 gliomas (81 astrocytomas, 8 ependymomas and 5 oligodendrogliomas) and in 100 healthy subjects by the polymerase chain reaction-restriction fragment length polymorphism approach. | 0.020878618 | 2008 | TP53 | 17 | 7676154 | G | T,C |
rs11133391 | 24135790 | 9575 | CLOCK | umls:C0028945 | BeFree | The variant allele for CLOCK rs11133391 under a recessive model increased risk of oligodendroglioma (OR 2.41; 95 % CI 1.31-4.42; p = 0.005), though not other glioma subtypes (p for heterogeneity = 0.0033). | 0.000271442 | 2013 | CLOCK | 4 | 55501788 | T | C |
rs11540654 | 18393224 | 7157 | TP53 | umls:C0028945 | BeFree | Aiming to study the role of TP53 Pro47Ser and Arg72Pro on glioma susceptibility and oncologic prognosis of patients, we investigated the genotype distribution of these SNPs in 94 gliomas (81 astrocytomas, 8 ependymomas and 5 oligodendrogliomas) and in 100 healthy subjects by the polymerase chain reaction-restriction fragment length polymorphism approach. | 0.020878618 | 2008 | TP53 | 17 | 7676040 | C | T,G,A |
rs118101777 | 25277207 | 3418 | IDH2 | umls:C0028945 | BeFree | The majority of oligodendrogliomas (ODGs) exhibit combined losses of chromosomes 1p and 19q and mutations of isocitrate dehydrogenase (IDH1-R132H or IDH2-R172K). | 0.245895776 | 2015 | IDH2 | 15 | 90087472 | C | T |
rs118101777 | 25277207 | 3417 | IDH1 | umls:C0028945 | BeFree | The majority of oligodendrogliomas (ODGs) exhibit combined losses of chromosomes 1p and 19q and mutations of isocitrate dehydrogenase (IDH1-R132H or IDH2-R172K). | 0.138783028 | 2015 | IDH2 | 15 | 90087472 | C | T |
rs121913500 | 23934175 | 3417 | IDH1 | umls:C0028945 | BeFree | We evaluated nuclear cMYC protein levels and IDH1 (R132H) by immunohistochemistry in patients with oligodendroglioma/oligoastrocytomas (n = 20), astrocytomas (grade II) (n = 19), anaplastic astrocytomas (n = 21) or glioblastomas (n = 111). | 0.138783028 | 2013 | IDH1 | 2 | 208248388 | C | T |
rs121913500 | 25277207 | 3417 | IDH1 | umls:C0028945 | BeFree | The majority of oligodendrogliomas (ODGs) exhibit combined losses of chromosomes 1p and 19q and mutations of isocitrate dehydrogenase (IDH1-R132H or IDH2-R172K). | 0.138783028 | 2015 | IDH1 | 2 | 208248388 | C | T |
rs121913500 | 25277207 | 3418 | IDH2 | umls:C0028945 | BeFree | The majority of oligodendrogliomas (ODGs) exhibit combined losses of chromosomes 1p and 19q and mutations of isocitrate dehydrogenase (IDH1-R132H or IDH2-R172K). | 0.245895776 | 2015 | IDH1 | 2 | 208248388 | C | T |
rs121913500 | 22385787 | 3417 | IDH1 | umls:C0028945 | BeFree | The mutation analysis performed on the latter case with DNA separately sampled from the oligodendroglioma- like area and the astrocytoma-like area detected IDH1 G395A in both areas. | 0.138783028 | 2012 | IDH1 | 2 | 208248388 | C | T |
rs121913500 | 23527265 | 3417 | IDH1 | umls:C0028945 | BeFree | This glioma xenograft is the first to display a pure oligodendroglioma histology and expression of R132H. | 0.138783028 | 2013 | IDH1 | 2 | 208248388 | C | T |
rs121913503 | 25277207 | 3418 | IDH2 | umls:C0028945 | BeFree | The majority of oligodendrogliomas (ODGs) exhibit combined losses of chromosomes 1p and 19q and mutations of isocitrate dehydrogenase (IDH1-R132H or IDH2-R172K). | 0.245895776 | 2015 | IDH2 | 15 | 90088606 | C | T |
rs121913503 | 25277207 | 3417 | IDH1 | umls:C0028945 | BeFree | The majority of oligodendrogliomas (ODGs) exhibit combined losses of chromosomes 1p and 19q and mutations of isocitrate dehydrogenase (IDH1-R132H or IDH2-R172K). | 0.138783028 | 2015 | IDH2 | 15 | 90088606 | C | T |
rs1800371 | 18393224 | 7157 | TP53 | umls:C0028945 | BeFree | Aiming to study the role of TP53 Pro47Ser and Arg72Pro on glioma susceptibility and oncologic prognosis of patients, we investigated the genotype distribution of these SNPs in 94 gliomas (81 astrocytomas, 8 ependymomas and 5 oligodendrogliomas) and in 100 healthy subjects by the polymerase chain reaction-restriction fragment length polymorphism approach. | 0.020878618 | 2008 | TP53 | 17 | 7676230 | G | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Disease ID | 663 |
---|---|
Disease | oligodendroglioma |
Case | (Waiting for update.) |